In the BioHarmony Drug Report Database
Testosterone enanthate
Delatestryl, Xyosted (testosterone enanthate) is a small molecule pharmaceutical. Testosterone enanthate was first approved as Delatestryl on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, and hypogonadism in the USA. Testosterone enanthate’s patents are valid until 2038-08-30 (FDA).
Trade Name
|
Delatestryl, Xyosted |
|---|---|
Common Name
|
testosterone enanthate |
ChEMBL ID
|
CHEMBL1200335 |
Indication
|
breast neoplasms, delayed puberty, hypogonadism |
Drug Class
|
Steroids (androgens, anabolics) |
Image (chem structure or protein)